Jessica Tassan
Stock Analyst at Piper Sandler
(1.01)
# 3,526
Out of 4,820 analysts
65
Total ratings
25%
Success rate
-11.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jessica Tassan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CVS CVS Health | Maintains: Overweight | $72 → $74 | $65.32 | +13.29% | 5 | Mar 21, 2025 | |
| CTEV Claritev | Maintains: Neutral | $10 → $19 | $23.16 | -17.96% | 1 | Mar 10, 2025 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $14 → $21 | $17.52 | +19.86% | 5 | Mar 4, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $13 → $12 | $7.20 | +66.67% | 6 | Feb 27, 2025 | |
| EVH Evolent Health | Reiterates: Overweight | $17 → $16 | $8.98 | +78.17% | 3 | Feb 21, 2025 | |
| HCAT Health Catalyst | Maintains: Overweight | $12 → $8 | $4.10 | +95.12% | 11 | Feb 11, 2025 | |
| PINC Premier | Maintains: Neutral | $21 → $19 | $20.06 | -5.28% | 5 | Feb 5, 2025 | |
| CI The Cigna Group | Reiterates: Overweight | $394 → $348 | $335.36 | +3.77% | 3 | Feb 3, 2025 | |
| PHR Phreesia | Reiterates: Overweight | $31 → $33 | $24.75 | +33.33% | 5 | Jan 29, 2025 | |
| HUM Humana | Maintains: Neutral | $270 → $288 | $264.40 | +8.93% | 3 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $605 → $600 | $418.64 | +43.32% | 5 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $28 | $12.22 | +129.13% | 4 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $23 | $56.65 | -59.40% | 3 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $66 → $70 | $30.95 | +126.21% | 4 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $100 → $70 | $7.73 | +805.56% | 2 | Feb 27, 2023 |
CVS Health
Mar 21, 2025
Maintains: Overweight
Price Target: $72 → $74
Current: $65.32
Upside: +13.29%
Claritev
Mar 10, 2025
Maintains: Neutral
Price Target: $10 → $19
Current: $23.16
Upside: -17.96%
Alignment Healthcare
Mar 4, 2025
Maintains: Overweight
Price Target: $14 → $21
Current: $17.52
Upside: +19.86%
Teladoc Health
Feb 27, 2025
Maintains: Overweight
Price Target: $13 → $12
Current: $7.20
Upside: +66.67%
Evolent Health
Feb 21, 2025
Reiterates: Overweight
Price Target: $17 → $16
Current: $8.98
Upside: +78.17%
Health Catalyst
Feb 11, 2025
Maintains: Overweight
Price Target: $12 → $8
Current: $4.10
Upside: +95.12%
Premier
Feb 5, 2025
Maintains: Neutral
Price Target: $21 → $19
Current: $20.06
Upside: -5.28%
The Cigna Group
Feb 3, 2025
Reiterates: Overweight
Price Target: $394 → $348
Current: $335.36
Upside: +3.77%
Phreesia
Jan 29, 2025
Reiterates: Overweight
Price Target: $31 → $33
Current: $24.75
Upside: +33.33%
Humana
Jan 15, 2025
Maintains: Neutral
Price Target: $270 → $288
Current: $264.40
Upside: +8.93%
Jan 2, 2025
Maintains: Overweight
Price Target: $605 → $600
Current: $418.64
Upside: +43.32%
Sep 10, 2024
Reiterates: Overweight
Price Target: $28
Current: $12.22
Upside: +129.13%
Nov 10, 2023
Maintains: Neutral
Price Target: $21 → $23
Current: $56.65
Upside: -59.40%
Aug 2, 2023
Downgrades: Neutral
Price Target: $66 → $70
Current: $30.95
Upside: +126.21%
Feb 27, 2023
Downgrades: Neutral
Price Target: $100 → $70
Current: $7.73
Upside: +805.56%